Mirtazapine Accord Healthcare

Mirtazapine, the active ingredient in Mirtazapine Accord Healthcare, is a NaSSA (noradrenergic and specific serotonergic antidepressant) presented as an oral tablet for oral use. It is indicated for the treatment of major depressive disorder in adult patients.

GNH USA supplies Mirtazapine Accord Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mirtazapine acts on central neurotransmitter pathways to treat depressive disorders.

Major depressive disorder: reduces depressive symptoms and improves mood in adults.

Mirtazapine may cause a range of adverse reactions.

Common Side Effects: - Sedation or drowsiness - Increased appetite leading to weight gain - Dry mouth - Constipation - Dizziness - Peripheral edema

Serious or Rare Side Effects: - Agranulocytosis or severe neutropenia - Suicidal thoughts, especially early in therapy - Hypersensitivity reactions such as rash or angioedema - Hepatic dysfunction - Serotonin syndrome when combined with other serotonergic agents - Severe hypotension

Before initiating therapy, consider the following precautions. - Assess psychiatric history: evaluate risk of suicidal ideation, especially in early treatment. - Monitor weight and metabolic parameters: track changes in appetite and body mass. - Check liver function: obtain baseline labs and repeat as clinically indicated. - Avoid abrupt discontinuation: taper under medical supervision to reduce withdrawal effects. - Caution in elderly: increased sensitivity to sedation and orthostatic hypotension. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Mirtazapine can interact with several drug classes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase mirtazapine plasma levels. - Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce therapeutic effect.

Moderate Interactions (Monitor Closely): - Other serotonergic agents (SSRIs, SNRIs, tramadol): monitor for serotonin syndrome. - Alcohol: may enhance central nervous system depression. - Benzodiazepines or other CNS depressants: additive sedative effects.